Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervers R, Lopez-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med. 1994;96(1):3–9.
2. Emmi G, Silvestri E, Squatrito D, Cluccciarelli L, Cameli AM, Denas G, et al. Approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. Sci World J. 2014;214:1–8.
https://doi.org/10.1155/2014/341342
.
3. Rossi A, Colorio C, Puente D, Forastiero R. An update on current management strategies for antiphospholipid syndrome-related thrombosis. Clin Lipidol. 2014;9(1):91–100.
4. Turiel M, Sarzi-Puttini P, Peretti R, Rossi E, Atzeni F, Parsons W, et al. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study. Stroke. 2005;36(7):1490–4.
https://doi.org/10.1161/01.str.0000170645.40562.09
.
5. de Carvalho JF, Caleiro MTC, Vendramini M, Bonfa E. Clinical and laboratory evaluation of patients with antiphospholipid syndrome according to the frequency of antinuclear antibodies (ANA Hep-2). Bras J Rheumatol. 2010;50(3):262–72.